Health-related quality of life after vitamin D supplementation in cancer survivors: A cross-sectional survey
Published
February 21, 2026
Paper ID
PAP-000165
Status
Published
DOI
10.65712/tmj.test000423
Advance Services
Abstract
Background: Earlier studies of vitamin D supplementation were small or single-centre. Methods: Analyses were adjusted for age, sex and baseline severity. Results: Serious adverse events were rare and similar between groups. 505 participants were included (median age 31 years). Conclusion: These findings suggest that vitamin D supplementation is associated with better health-related quality of life in cancer survivors.
Introduction
Practice around vitamin D supplementation varies widely between centres. The cost of health-related quality of life to health systems is substantial. Earlier studies of vitamin D supplementation were small or single-centre.
Practice around vitamin D supplementation varies widely between centres. health-related quality of life remains a leading cause of avoidable harm among cancer survivors.
health-related quality of life remains a leading cause of avoidable harm among cancer survivors. Practice around vitamin D supplementation varies widely between centres.
Materials and Methods
The primary outcome was health-related quality of life, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity.
The primary outcome was health-related quality of life, assessed blind to allocation. Eligible participants were cancer survivors.
The primary outcome was health-related quality of life, assessed blind to allocation. Eligible participants were cancer survivors.
Results
Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.85 (95% CI 0.26 to 0.72).
| Group | n | Events | Rate % | OR | 95% CI |
|---|---|---|---|---|---|
| Male | 556 | 16 | 34.8 | 0.98 | 0.32–1.0 |
| Control | 117 | 71 | 37.9 | 0.40 | 0.56–1.16 |
| Centre A | 36 | 55 | 29.6 | 0.49 | 0.48–1.13 |
| Female | 332 | 80 | 38.5 | 0.55 | 0.53–1.15 |
Values are n (%) unless stated otherwise.

Shown for cancer survivors; error bars are 95% confidence intervals.

Shown for cancer survivors; error bars are 95% confidence intervals.
Serious adverse events were rare and similar between groups. health-related quality of life occurred in 10% of the intervention group versus 16% of controls.
Discussion
These findings suggest that vitamin D supplementation is associated with better health-related quality of life in cancer survivors. Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.
Future work should test vitamin D supplementation in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols.
Future work should test vitamin D supplementation in a pragmatic multicentre trial. Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment.
Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded.
Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols.
Conclusions
Vitamin D supplementation should be considered for cancer survivors to improve health-related quality of life.
References
1. Andersen W, Mensah E, et al. An antibiotic stewardship programme and time to diagnosis. Lancet. 2019;92(1):588-1314.
2. Ibrahim S, Tanaka A, et al. Vitamin D supplementation and acute kidney injury. Eur Heart J. 2015;212(1):762-1733.
3. Haddad U, Novak T, et al. Frailty screening and 30-day readmission. Crit Care Med. 2011;268(9):856-1304.
4. Nakamura K, Ibrahim L, et al. Machine-learning triage and post-operative delirium. Diabetes Care. 2022;221(9):473-1693.
5. Rossi T, Andersen Z, et al. Point-of-care ultrasound and patient satisfaction. Ann Intern Med. 2018;382(7):474-1410.
6. Mensah F, Kim T, et al. Tranexamic acid and medication adherence. Eur Heart J. 2009;124(5):193-1512.
7. Rossi I, Lindqvist L, et al. Point-of-care ultrasound and ventilator-free days. BMC Med. 2024;311(11):142-966.
8. Nasser L, Nakamura R, et al. Low-dose aspirin and surgical site infection. BMC Med. 2014;73(11):68-1546.
Appendices
Supplementary tables are available on request.